# data[].attributes.body
I think this is a wonderful technology for people suffering from insulin dependent diabetes.  I have multiple friends with the disease that have to work extremely hard every day to take care of themselves.  I would love for this technology to become more widely available for the public to use. I can see where this technology will help so many people in their day to day lives. It will make them safer and more compliant with their treatment.

# data[].attributes.attachment_link.title
Introducing the MiniMed 670G Hybrid Closed Loop System

# data[].attributes.attachment_link.description
Introducing the world's first hybrid closed loop system for people with type 1 diabetes, brought to you by Medtronic. The MiniMed® 670G system is the latest step toward a fully automated closed loop system. It includes the new Guardian® Sensor 3 and most advanced version of our SmartGuard® HCL technology.

# data[].attributes.body
Peyser, T., Dassau, E., Breton, M. and Skyler, J. S. (2014), The artificial pancreas: current status and future prospects in  the management of diabetes. Annals of the New York Academy of Sciences, 1311: 102–123. doi: 10.1111/nyas.12431
http://onlinelibrary.wiley.com/wol1/doi/10.1111/nyas.12431/full
https://www.youtube.com/watch?v=txpwSqOnKoI

# data[].attributes.body
As nurses, this would be helpful in an outpatient setting.  Patients would be able to give accurate records detailing their glucose and insulin need trends.  Nurses could then help provide lifestyle counseling based on those records. If the technology is able to send the information to a cloud that is then accessed by a provider they can call patients if they are noticing unsafe trends in their blood sugar levels or insulin usage in a prompt timeframe.

# data[].attributes.body
Technology failure

Not an all-in-one system

Not extensively studied with exercise, illness, and poor diet control

# data[].attributes.body
Less human error

Less "sticks" throughout the day

More accurate data records

# data[].attributes.body
For more than 50 years scientists have been trying to create a more efficient and easy way for people that live with insulin dependent diabetes to control their disease.  For most people, they would have to check their blood sugar multiple times a day and then give themselves insulin injections based on their blood levels and their carbohydrate count.  This leaves a lot of room for human error.  Hypoglycemia is one of the most dangerous complications of this system.  To help prevent these events from occurring so frequently, researchers have finally developed a system that helps eliminate human error and the number of needles a person must endure in a day.  In 2016, the US FDA approved the first artificial pancreas for use.  The device includes a continuous glucose monitoring device, an insulin pump, and an algorithm that controls the system.  The algorithm can be changed based on illness, physical exercise, or increased carbohydrate consumption.